由Akt2-PDK1信号诱导的乳酸积累促进了肺纤维化
Zhiheng Sun1,2,3, Zhihua Ji1,2,3, Wanyu He1,2,3
1College of Life Science, Institute of Biomedical Science, Henan Normal University, Xinxiang, China.
概括
异形性肺纤维化 (IPF) 涉及肺组织痕和增加糖解. 这项研究表明,PDK1促进糖解和纤维化,通过抑制Akt2和PDK1.1,提供新的治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性肺病,其特征是纤维组织的积累.
- 在IPF中观察到高糖解和乳酸积累,但潜在的机制需要进一步阐明.
- 目前IPF的治疗选择有限.
研究的目的:
- 调查糖解和乳酸积累在白素 (BLM) 诱导的肺纤维化中的作用.
- 鉴定IPF中调节糖解的关键分子机制.
- 探索IPF的潜在治疗点.
主要方法:
- 使用白素 (BLM) 诱导小鼠的肺纤维化模型.
- 在体外研究中,使用用TGF-β1和BLM刺激的膜表皮和肺纤维细胞系.
- 检测乳酸水平,纤维细胞标记物和蛋白质表达 (PDK1,Akt2).
主要成果:
- BLM诱导的肺纤维化与增加的葡萄糖分解和乳酸积累有关.
- 纤维化肺组织中PDK1表达的升高促进了糖解.
- PDK1刺激了肺纤维细胞转分化和膜上皮细胞EMT.
- 化Akt2激活了PDK1,驱动了纤维化过程.
- 抗Akt2和PDK1的抑制剂抑制了纤维化的进展.
结论:
- 通过糖解的PDK1-促进的乳酸积累是肺纤维化的一个关键因素.
- 该Akt2-PDK1通路在促进纤维化方面发挥着至关重要的作用.
- 准Akt2和PDK1为IPF提供了一个有前途的治疗策略.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Muscle Recovery and Fatigue
2.1K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.1K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


